Chemical Group Profiling, and Evaluation of on -Amylase and -Glucosidase Activity.

Diabetes mellitus (DM) has become a global scourge, and there is a continuous search for novel compounds as viable alternatives to synthetic drugs which are often accompanied by severe adverse effects. is among the scientifically implicated botanicals effective in the management of several degenerative diseases including DM. The current study evaluated the inhibitory mechanism(s) of root extract of on -amylase and -glucosidase and , while its constituents were characterized using liquid chromatography-mass spectrometric technique. The extract had concentration-dependent inhibitory effect on the study enzymes, and the inhibition compared well with that of standard drug (acarbose) with respective IC values of 0.67 mg/mL (-amylase) and 0.57 mg/mL (-glucosidase) compared with that of the extract (0.63 and 0.54 mg/mL). The extract competitively and uncompetitively inhibited -amylase and -glucosidase, respectively. Of the identified compounds, dianoside (-12.4, -12.5 kcal/mol) and trilobine (-10.0, -10.0 kcal/mol) had significant interactions with -amylase and -glucosidase, respectively, while magnoflorine and asiatic acid also interacted keenly with both enzymes, with quercetin 3-O-glucuronide and strictosidine showing better affinity towards -glucosidase. These observations are suggestive of involvement of these compounds as probable ligands contributing to antidiabetic potential of the extract. While studies are underway to demystify the yet to be identified compounds in the extract, the data presented have lent scientific credence to the acclaimed antidiabetic potential of the extract and suggested it as a viable source of oral hypoglycaemic agent.